Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Epidemiological and economic impact of pandemic influenza in Chicago: Priorities for vaccine interventions.

Dorratoltaj N, Marathe A, Lewis BL, Swarup S, Eubank SG, Abbas KM.

PLoS Comput Biol. 2017 Jun 1;13(6):e1005521. doi: 10.1371/journal.pcbi.1005521. eCollection 2017 Jun.

2.

Comparison of Side Effects of the 2015-2016 High-Dose, Inactivated, Trivalent Influenza Vaccine and Standard Dose, Inactivated, Trivalent Influenza Vaccine in Adults ≥65 Years.

Kaka AS, Filice GA, Myllenbeck S, Nichol KL.

Open Forum Infect Dis. 2017 Jan 12;4(1):ofx001. doi: 10.1093/ofid/ofx001. eCollection 2017 Winter.

3.

Influenza vaccination in the elderly: why are the overall benefits still hotly debated?

Trucchi C, Paganino C, Orsi A, De Florentiis D, Ansaldi F.

J Prev Med Hyg. 2015 Jun 10;56(1):E37-43. Review.

4.

The Role of Research in Integrated Health Care Systems: The HMO Research Network.

Vogt TM, Lafata JE, Tolsma DD, Greene SM.

Perm J. 2004 Fall;8(4):10-7.

5.

Association between monovalent influenza A (H1N1) pdm09 vaccine and pneumonia among the elderly in the 2009-2010 season in Japan: A case-control study.

Kondo K, Suzuki K, Washio M, Ohfuji S, Fukushima W, Maeda A, Hirota Y; Pneumonia in Elderly People Study Group.

Hum Vaccin Immunother. 2015;11(5):1088-93. doi: 10.1080/21645515.2015.1016668. Erratum in: Hum Vaccin Immunother. 2015;11(10):2510.

6.

Cystine and theanine: amino acids as oral immunomodulative nutrients.

Kurihara S, Shibakusa T, Tanaka KA.

Springerplus. 2013 Nov 26;2:635. doi: 10.1186/2193-1801-2-635. Review.

7.

Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.

Ott JJ, Klein Breteler J, Tam JS, Hutubessy RC, Jit M, de Boer MR.

Hum Vaccin Immunother. 2013 Jul;9(7):1500-11. doi: 10.4161/hv.24704. Epub 2013 May 31. Review.

8.

Additive preventive effect of influenza and pneumococcal vaccines in the elderly: results of a large cohort study.

Mahamat A, Daurès JP, de Wzieres B.

Hum Vaccin Immunother. 2013 Jan;9(1):128-35. doi: 10.4161/hv.22550.

9.

Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V ® and Fluad ® ) in preventing hospitalization for influenza and pneumonia in the elderly: a matched case-control study.

Gasparini R, Amicizia D, Lai PL, Rossi S, Panatto D.

Hum Vaccin Immunother. 2013 Jan;9(1):144-52. doi: 10.4161/hv.22231. Epub 2012 Nov 10.

10.

Cost-effectiveness of polysaccharide pneumococcal vaccination in people aged 65 and above in Poland.

Grzesiowski P, Aguiar-Ibáñez R, Kobryń A, Durand L, Puig PE.

Hum Vaccin Immunother. 2012 Oct;8(10):1382-94. doi: 10.4161/hv.21571. Epub 2012 Oct 1.

11.

A surveillance system to reduce transmission of pandemic H1N1 (2009) influenza in a 2600-bed medical center.

Chu TP, Li CC, Wang L, Hsu LW, Eng HL, You HL, Liu JW, Wei CC, Chang LS, Lee IK, Yang KD.

PLoS One. 2012;7(3):e32731. doi: 10.1371/journal.pone.0032731. Epub 2012 Mar 13.

12.

Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence.

Lang PO, Mendes A, Socquet J, Assir N, Govind S, Aspinall R.

Clin Interv Aging. 2012;7:55-64. doi: 10.2147/CIA.S25215. Epub 2012 Feb 24. Review.

13.

Efficacy of a vaccine that links viral epitopes to flagellin in protecting aged mice from influenza viral infection.

Leng J, Stout-Delgado HW, Kavita U, Jacobs A, Tang J, Du W, Tussey L, Goldstein DR.

Vaccine. 2011 Oct 19;29(45):8147-55. doi: 10.1016/j.vaccine.2011.08.027. Epub 2011 Aug 18.

14.

Influenza vaccine effectiveness in the elderly based on administrative databases: change in immunization habit as a marker for bias.

Hottes TS, Skowronski DM, Hiebert B, Janjua NZ, Roos LL, Van Caeseele P, Law BJ, De Serres G.

PLoS One. 2011;6(7):e22618. doi: 10.1371/journal.pone.0022618. Epub 2011 Jul 26.

15.

Does influenza vaccination of older adult Medicare beneficiaries lower treatment costs for acute and chronic respiratory disease?

Stuart B, Davidoff A, Lloyd J, Shaffer T, Shoemaker JS, Kemner J.

Am J Geriatr Pharmacother. 2010 Jun;8(3):201-14. doi: 10.1016/j.amjopharm.2010.05.003.

16.

Development and testing of a vaccination message targeted to persons with spinal cord injuries and disorders.

LaVela SL, Cameron KA, Priebe M, Weaver FM.

J Spinal Cord Med. 2008;31(1):44-52.

17.

Effect of influenza and pneumococcal vaccines in elderly persons in years of low influenza activity.

Christenson B, Pauksen K, Sylvan SP.

Virol J. 2008 Apr 28;5:52. doi: 10.1186/1743-422X-5-52.

18.

Expanding the delivery of clinical preventive services through community collaboration: the SPARC model.

Shenson D, Benson W, Harris AC.

Prev Chronic Dis. 2008 Jan;5(1):A20. Epub 2007 Dec 15.

19.

Prevention and control of influenza in persons with chronic obstructive pulmonary disease.

Plans-Rubió P.

Int J Chron Obstruct Pulmon Dis. 2007;2(1):41-53. Review.

20.

Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults.

Durando P, Fenoglio D, Boschini A, Ansaldi F, Icardi G, Sticchi L, Renzoni A, Fabbri P, Ferrera A, Parodi A, Bruzzone B, Gabutti G, Podda A, Del Giudice G, Fragapane E, Indiveri F, Crovari P, Gasparini R.

Clin Vaccine Immunol. 2008 Feb;15(2):253-9. Epub 2007 Nov 14.

Supplemental Content

Support Center